Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

for
Chronic Graft-versus-Host-Disease,
Location: Toronto, Saint Louis MO, Omaha NE, Portland OR
Sponsor: University of British Columbia

Sex: All

Age: 18+

Code: NCT05692713

Recruiting

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

for
Multiple Myeloma, Autologous Stem Cell Transplantation
Location: Augusta GA
Sponsor: Augusta University

Sex: All

Age: 18+

Code: NCT06588413

Phase 3, Recruiting

Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study

for
Chronic Graft-versus-Host-Disease, Leukemia,
Location: New York NY, Montreal, Buffalo NY, Charlotte NC,
Sponsor: University of British Columbia

Sex: All

Age: 0 - 24

Code: NCT04372524

Recruiting

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

for
Peripheral Blood Stem Cell Transplantation,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT05436418

Phase 1, Phase 2, Recruiting

Employment Support After Hematopoietic Stem Cell Transplantation

for
Hematopoietic Stem Cell Transplantation
Location: Boston MA
Sponsor: MGH Institute of Health Professions

Sex: All

Age: 18 - 70

Code: NCT06494423

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Intestinal Microbiota in Stem Cell Transplant Transplant Admission

for
Stem Cell Transplant Complications
Location: Detroit MI
Sponsor: Henry Ford Health System

Sex: All

Age: 18 - 70+

Code: NCT04623424

Recruiting

Loratadine for the Prevention of G-CSF-related Bone Pain

for
Stem Cell Transplant Complications
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05421416

Phase 2, Recruiting

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency

for
Limbal Stem Cell Deficiency
Location: Indianapolis IN, Carmel IN, Minnetonka MN,
Sponsor: Claris Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06452316

Phase 1, Recruiting

Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

for
Amputation, Skin Wound, Stem Cell
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 65

Code: NCT03947450

Phase 2, Recruiting

Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection

for
Stem Cell Transplant, Allogeneic
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0 - 70

Code: NCT01189786

Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD),
Location: Boston MA, Philadelphia PA, Washington D.C. DC,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 0+

Code: NCT03394365

Phase 3, Recruiting

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

for
Multiple Myeloma, Stem Cell Transplant Complications
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT05706766

Recruiting

High Heated Humidity in Stem Cell Transplant

for
Autologous Stem Cell Transplant
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05358262

Phase 2, Recruiting

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

for
Cellular Immunotherapy, Adoptive, Genetic Therapy,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 4 - 70+

Code: NCT03000244

Recruiting

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

for
Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06377540

Phase 2, Recruiting

Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

for
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 5 - 70

Code: NCT06093867

Recruiting

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

for
Viral Infection, Hematopoietic Stem Cell Transplantation (HSCT),
Location: Baltimore MD, Washington D.C. DC, Bethesda MD
Sponsor: Children's National Research Institute

Sex: All

Age: 0 - 70+

Code: NCT04691622

Phase 1, Recruiting

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

for
Autologous Stem Cell Transplantation,
Location: New Brighton MN
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT04920474

Recruiting

Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency

for
Limbal Stem Cell Deficiency
Location: Quebec, Montreal, Toronto
Sponsor: CHU de Quebec-Universite Laval

Sex: All

Age: 1+

Code: NCT01756365

Recruiting

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

for
CMV, Allogeneic Stem Cell Transplantation
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06453460

Phase 2, Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial